Assoian, R. K. and Sporn, M. B (1986). Typetransforming growth factor in human platelets: Release during platelet degranulation and action on vascular smooth muscle cells. J. Cell Biol 102, 1217-1223.[Abstract/Free Full Text]
Assoian, R. K., Fleurdelys, B. E., Stevenson, H. C., Miller, P. J., Madtes, D. K., Raines, E. W., Ross, R. and Sporn, M. B (1987). Expression and secretion of typetransforming growth factor by activated human macrophages. Proc. Nat. Acad. Sci USA 84, 6020-6024.[Abstract/Free Full Text]
Baird, A., Mormede, P. and B\232hlen, P (1985). Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. Biochem. Biophys. Res. Commun 126, 358-364.[Medline]
Battegay, E. J., Raines, E. W., Seifert, R. A., Bowen-Pope, D. F. and Ross, R (1990). TGFinduces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63, 515-524.[Medline]
Besner, G. E. and Klagsbrun, M (1991). Macrophages secrete a heparin-binding inhibitor of endothelial cell growth. Microvasc. Res 42, 187-197.[Medline]
Bittermann, P. B., Rennard, S. I., Hunninghake, G. W. and Crystal, R. G (1982). Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization. J. Clin. Invest 70, 806-822.
Calderon, J., Williams, R. T. and Unanue, E. R (1974). An inhibitor of cell proliferation released by cultures of macrophages. Proc. Nat. Acad. Sci. USA 71, 4273-4277.[Abstract/Free Full Text]
Calderon, J. and Unanue, E. R (1975). Two biological activities regulating cell proliferation found in cultures of peritoneal exudate cells. Nature 253, 359-361.[Medline]
Chen, A. R., Mc Kinnon, K. P., Koren, H. S (1985). Lipopolysaccharide stimulates fresh human monocytes and lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumour necrosis factor. J. Immunol 135, 3978-3987.[Abstract]
Delustro, F., Sherer, G. K. and Leroy, E. C (1980). Human monocyte stimulation of fibroblast growth by a soluble mediator(s). J. Reticuloendothel. Soc 28, 519-532.[Medline]
Dempsey, E. C., McMurtry, I. F. and O'Brien, R. F (1991). Protein kinase C activation allows pulmonary artery smooth muscle cells to proliferate to hypoxia. Am. J. Physiol 260, 136-.
Estes, J. E., Pledger, W. J. and Gillespie, G. Y (1984). Macrophage-derived growth factor for fibroblasts and interleukin-1 are distinct entities. J. Leuk. Biol 35, 115-129.[Abstract]
Faggiotto, A. and Ross, R (1984). Studies of hypercholesterolemia in the nonhuman primate: II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 4, 341-356.[Abstract/Free Full Text]
Gerrity, R. G (1981). The role of the monocyte in atherogenesis 1. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol 103, 181-190.[Abstract]
Gerrity, R. G (1981). The role of the monocyte in atherogenesis 2. Migration of foam cells from atherosclerotic lesions. Am. J. Pathol 103, 191-200.[Abstract]
Glenn, K. C and Ross, R (1981). Human monocyte-derived growth factor(s) for mesenchymal cells: Activation of secretion by endotoxin and concanavalin A. Cell 25, 603-615.[Medline]
Huang, C.-L. and Ives, H. E (1987). Growth inhibition by protein kinase C late in mitogenesis. Nature 329, 849-850.[Medline]
Jonasson, L., Holm, J., Skalli, O., Bondjers, G. and Hansson, G. K (1986). Regional accumulations of T cells, macrophages and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6, 131-138.[Abstract/Free Full Text]
Joris, I. and Majno, G (1977). Atherosclerosis and inflammation. Advan. Exp. Med. Biol 104, 227-243.
Leslie, C. C., Musson, R. A. and Henson, P. M (1984). Production of growth factor activity for fibroblasts by human monocyte-derived macrophages. J. Leuk. Biol 36, 143-159.[Abstract]
Libby, P., Warner, S. J. C. and Friedman, G. B (1988). Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J. Clin. Invest 81, 487-498.
Martin, B. M., Gimbrone, M. A. Jr, Unanue, E. R. and Cotran, R. S (1981). Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor. J. Immunol 126, 1510-5.[Abstract]
McMurray, H. F., Proudfoot, D., Davis, J. B., Parrott, D. P. and Bowyer, D. E (1993). A small molecular weight inhibitor of growth of 3T3 cells and porcine aortic smooth muscle cells released from the macrophage cell line P388D1. J. Cell Sci 106, 1301-1311.[Abstract]
Nathan, C. F (1987). Secretory products of macrophages. J. Clin. Invest 79, 319-326.
Owen, N. E (1985). Effect of TPA on ion fluxes and DNA synthesis in vascular smooth muscle cells. J. Cell Biol 101, 454-459.[Abstract/Free Full Text]
Pannel, R. and Milstein, C (1992). An oscillating bubble chamber for laboratory scale production of monoclonal antibodies as an alternative to ascitic tumours. J. Immunol. Meth 146, 43-48.[Medline]
Parrott, D. P., Goldberg, R. L., Kaplan, S. R. and Fuller, G. C (1982). The effect of lymphokines on proliferation and collagen synthesis of cultured human synovial cells. Eur. J. Clin. Invest 12, 407-415.[Medline]
Porrecca, E., Ciccarelli, R., Di Febbo, C. and Cuccurullo, F (1993). Protein kinase C pathway and proliferative responses of aged and young rat vascular smooth muscle cells. Atherosclerosis 104, 137-145.[Medline]
Rennick, R. E., Campbell, J. H. and Campbell, G. R (1988). Vascular smooth muscle phenotype and growth behavior can be influenced by macrophages in vitro. Atherosclerosis 71, 35-43.[Medline]
Roberts, A. B., Anzano, M. A., Wakefield, L. M., Roche, N. S. and Stern, D. F (1985). Typetransforming growth factor: A bifunctional regulator of cell growth. Proc. Nat. Acad. Sci USA 82, 119-123.[Abstract/Free Full Text]
Ross, R (1986). The pathogenesis of atherosclerosis- an update. New Eng. J. Med 314, 488-500.[Medline]
Sasaguri, T., Kosaka, C., Hirata, M., Masuda, J., Shimokado, K., Fujishima, M. and Ogata, J (1993). Protein kinase C-mediated inhibition of vascular smooth muscle cell proliferation: The isoforms that may mediate G1/S inhibition. Exp. Cell Res 208, 311-320.[Medline]
Shimokado, K., Raines, E. W., Madtes, D. K., Barrett, T. B., Benditt, E. P. and Ross, R (1985). A significant part of macrophage-derived growth factor consists of at least two forms of platelet-derived growth factor. Cell 43, 277-286.[Medline]
Sj\232lund, M., Nilsson, J., Palmberg, L. and Thyberg, J (1984). Phenotype modulation in primary cultures of arterial smooth muscle cells: dual effect of prostaglandin E1. Differentiation 27, 158-162.[Medline]
Uehara, Y., Ishimitsu, T., Kimura, K., Ikeda, T. and Sugimoto, T (1988). Regulatory effects of eicosanoids on thymidine uptake by vascular smooth muscle cells of rats. Prostaglandins 36, 847-857.[Medline]
Vilette, D., Detiadi, H., Wautier, M. P., Caen, J., Wautier, J. L (1990). Identification of an endothelial cell growth-inhibitory activity produced by human monocytes. Exp. Cell Res 188, 219-225.[Medline]
Walker, L. N. and Bowyer, D. E (1984). Endothelial healing in the rabbitaorta and the effect of risk factors for atherosclerosis. Arteriosclerosis 4, 479-488.[Abstract/Free Full Text]
Wharton, W., Gillespie, G. Y., Russell, S. W. and Pledger, W. J (1982). Mitogenic activity elaborated by macrophage-like cell lines acts as competence factor(s) for Balb/c 3T3 cells. J. Cell. Physiol 110, 93-100.[Medline]
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
